Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Cellebrite DI's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $49.5 million for Q4 2025.

• In Q4 2025, Non-Current Deffered Revenue rose 9.46% year-over-year to $49.5 million; the TTM figure through Dec 2025 stood at $49.5 million (up 9.46% YoY), while the FY2025 annual figure was $49.5 million, up 9.46% from the prior year.
• Non-Current Deffered Revenue was $49.5 million for Q4 2025 at Cellebrite DI, up from $45.2 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $49.5 million in Q4 2025 to a low of $34.4 million in Q3 2021.
• Historically, Non-Current Deffered Revenue has averaged $42.5 million across 5 years, with a median of $43.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue climbed 15.78% in 2022, then retreated 3.93% in 2024.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $36.4 million in 2021, then advanced by 15.78% to $42.2 million in 2022, then rose by 11.68% to $47.1 million in 2023, then dropped by 3.93% to $45.2 million in 2024, then increased by 9.46% to $49.5 million in 2025.
• The last three Non-Current Deffered Revenue figures came in at $49.5 million (Q4 2025), $45.2 million (Q4 2024), and $47.1 million (Q4 2023), per Business Quant data.